Medanta Hospital
Immunotherapy for prostate cancer in India typically costs from AUD $12,900 to AUD $23,000. Prices change based on the specific drug, number of cycles, and required biomarker testing. In Australia, patients often face costs around AUD $30,900 for similar private treatments. By choosing India, Australians can save approximately 42%. Treatment usually includes oncology consultations and drug administration in major hubs like Mumbai, Delhi, and Bengaluru.
Bookimed Expert Insight: Indian clinics offer high-level precision by using AI for treatment planning. Manipal Goa Hospital uses IBM Watson for oncology to tailor immunotherapy doses accurately. For complex cases, specialists like Dr. Shruti Kate at HCG Manavata Cancer Centre coordinate advanced protocols. Facilities such as Global Hospital Chennai, which serves 80,000 patients annually, provide high-capacity care that helps reduce the wait times Australians often face.
| India | Thailand | Turkey | |
| Immunotherapy for prostate cancer | ≈ AUD $12,900 | ≈ AUD $17,200 | from AUD $11,500 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy for prostate cancer upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy for prostate cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy for prostate cancer journey.
The doctor graduated with a Bachelor of Medicine from Mysore University in 1996, followed by a Doctor of Medicine in radiotherapy from Banaras Hindu University in 2002. Further enhancing expertise, the doctor earned a Diplomate of National Board in radiotherapy in 2004.
The doctor is a member of several prestigious organizations, including the Association of Radiation Oncology of India, the Society for Neuro-Oncology, the Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology, reflecting a strong commitment to advancing the field of oncology.
Dr Chaitainya Borde has managed over 30,000 PET scans at HCG Manavata Cancer Centre – one of India's most active oncology hubs.
Dr. Shruti Kate is a medical oncologist at HCG Manavata Cancer Centre in Nashik. She previously worked as a consultant at the Tata Memorial Hospital in Mumbai. Dr. Kate focuses on immunotherapy and metronomic therapy for treating solid and pediatric tumors. She was the sole recipient from India of the 2018 World Conference on Lung Cancer award.
Dr. Ahmer Arif Shaikh is a surgical oncologist at HCG Manavata Cancer Centre. He specializes in oral cancer treatment with a focus on organ preservation. Dr. Shaikh completed fellowship training in head and neck surgical oncology at the same center. He is proficient in performing major maxillofacial and head and neck surgeries.